Merus
AcquiredClosing in on cancer
Public · Utrecht, Netherlands · Founded 2003 · $156.0M raised
- Total Funding
- $156.0M
- Last Round
- $83.0M Series CAug 2015
- Rounds
- 5
- Type
- Public
- Acquired by
- Genmab A/SSep 2025 · $8.0B
About
Merus N.V. is a clinical-stage oncology company headquartered in Utrecht, Netherlands, that develops innovative multispecific antibody therapeutics for cancer patients using its proprietary Multiclonics® platform. Founded in June 2003, Merus engineers full-length human IgG bispecific (Biclonics®) and trispecific (Triclonics®) antibodies that simultaneously engage multiple cancer targets, enabling novel mechanisms of action not achievable with conventional monoclonal antibodies. Its lead asset, petosemtamab, targets EGFR and LGR5 and is advancing in Phase 3 trials for recurrent or metastatic head and neck cancer. The company also maintains a US office in Cambridge, Massachusetts, and was acquired by Genmab in 2025, joining a global leader in antibody therapeutics.
Summary
Merus is a Biotech company based in Utrecht, Netherlands, founded in 2003. It has raised $156.0M in total across 5 rounds, most recently a $83.0M Series C round in Aug 2015. Investors include Genmab, Novo Holdings A/S and Sofinnova Partners.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2025
Sign up to see all 7 rounds
Seed through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/merus"><img src="https://indexed.vc/api/badge/company/merus" alt="Merus on Indexed.vc" width="260" height="76" /></a>